Status:
UNKNOWN
Analgesic Efficacy of Dexmedetomidine as Adjuvant to Levobupivacaine in Ultrasound-guided Erector Spinae Plan Block for Modified Radical Mastectomy
Lead Sponsor:
South Egypt Cancer Institute
Conditions:
Acute Pain
Eligibility:
FEMALE
25-70 years
Phase:
PHASE2
PHASE3
Brief Summary
To evaluate the analgesic efficacy of dexmedetomidine as adjuvants to levobupivacaine in erector spinae plane block in modified radical mastectomy surgery.
Detailed Description
Premedication will be given, after complete fasting hours after applying standard monitors (noninvasive blood pressure, pulse oximetery, ECG, temperature and capnography), an intravenous cannula will ...
Eligibility Criteria
Inclusion
- female patient
- American society of anesthesiologists (ASA) I and II physical status
- age from 25 to 70 years old
- scheduled for either left or right modified radical mastectomy (MRM).
Exclusion
- infection of the skin at or near site of needle puncture,
- coagulopathy,
- drug hypersensitivity or allergy to the studied drugs,
- central or peripheral neuropathy,
- significant organ dysfunction cardiac dysrrhythmias,
- obesity (BMI\>35kg/m2)
- recently use analgesic drugs.
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 28 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04732377
Start Date
November 1 2020
End Date
December 28 2021
Last Update
February 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute
Asyut, Egypt, 171516